Small Pharma Announces Further Positive Data from SPL026
Scientists have revealed further positive results from the first placebo-controlled study of a short-duration psychedelic therapy for the treatment of Major Depressive Disorder (MDD) in the UK. The BBC’s weekly The Lancet series profiles different researchers from around the world.
Source: globenewswire.comPublished on 2023-03-07
Related news
- Most Aussies are wary of open data : survey
- LocalGov . co . uk - Your authority on united kingdom local government - Moving beyond digital service delivery in local government
- Self - governing open finance body will be ready this year – BSP – Manila Bulletin
- Majority of Australians are not comfortable with open data , study finds
- Lafayette school trustee : Who benefits from school choice ?
- Democratisation of tertiary education , By Rahma Oladosu
- EU Cohesion policy : €3 . 7 billion from REACT - EU to support measures for recovery and digital and green transition in Spain
- Governance key to investments , growth – analysts
- Ocean Networks Canada initiative at UVic receives federal funding
- Data sharing by PSUs crossing the last mile - The Hindu BusinessLine
- Data governance : new rules to boost data sharing across the EU
- Seelos Therapeutics Announces Dosing of the First Patients in a Study of SLS - 002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder
- Study finds few Australians are comfortable with open data
- LocalGov . co . uk - Your authority on united kingdom local government - How can better use of data benefit public services ?
- The 2021 Ebbe Nielsen Challenge for open - data innovations for biodiversity